To Compare the Efficacy of Intralesional Saline Versus 35% Trichloracetic Acid (TCA) Peel in the Treatment of Atrophic Acne Scars

Sheikh Zayed Medical College

Status and phase: Completed; Phase 2

Conditions: Atrophic Acne Scarring; Atrophic Acne Scar

Treatments: Procedure: Intralesional Saline; Procedure: 35% trichloracetic acid peel

Study type: Interventional

Funder types: Other

Identifiers

NCT06789874

Sheikhzayedmedicalcollege SZMC

Details and patient eligibility

About

This study aimed to compare the efficacy of intradermal normal saline versus trichloroacetic acid (TCA) in treating atrophic acne scars. Atrophic acne scars are a common and disfiguring complication, with limited research on the use of normal saline.

Full description

Acne vulgaris is a common skin problem affecting adolescents and adults. It is the eighth most common skin disease globally, having a prevalence ranging from 35%-85%, with notable variations across different regions and age groups.A randomized controlled trial was conducted at the Dermatology Department, Sheikh Zayed Hospital, Rahim Yar Khan, from 1st April 2023 to 31st October 2023. 126 patients were enrolled. Scar grading was based on Goodman and Baron's Qualitative Scar Classification. The Observer Scar Assessment Scale (OSAS) was used by dermatologists. Patients rated their acne scars using the Visual Disease Severity Scale. Photographs were taken for comparison. Efficacy was defined as ≥50% improvement in the OSAS.

Enrollment: 126 patients

Sex: All

Ages: 16 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age: 13-50 years
• Clinically diagnosed patients of atrophic acne scars on face
• duration of more than 6 months
• no history of any procedural intervention in past 3 months

Exclusion criteria

• history of keloid, active acne, local infection, skin allergies, hypertrophic scarring, photosensitivity, or history of any comorbidities
• history of use of oral isotretinoin, OCPs, steroids or immunosuppressants
• pregnant or lactating females

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

126 participants in 2 patient groups

Intralesional Saline for acne scars (Group A)

Active Comparator group

Description:

Intralesional Saline 5 to 10ml injected in the sacrs fortnightly for 3 months

Treatment:

Procedure: Intralesional Saline

Topical Trichloracetic acid for acne scars(Group B)

Active Comparator group

Description:

35% trichloroacetic acid peel was applied to scars monthly for 3 months

Treatment:

Procedure: 35% trichloracetic acid peel